![](https://images.squarespace-cdn.com/content/v1/603f8624a2120f0be59da673/3e3d6c3a-4937-41ee-828a-29a09cf83ca5/EnteroBiotix-Header-Pipeline.jpg)
Clinical pipeline
R&D pipeline highlights
Delivered mechanistic PoC in cirrhosis/HE Ph1b
Completed enrolment in n=122 Ph2 IBS trial. Delivered safety & efficacy data from IBS-C cohort
Delivering Ph2 trial in allo-HSCT in collaboration with Imperial College
Available data suggests that drug has robust safety and tolerability profile
Proprietary stabilising technology demonstrated 12 months of stability at ambient temperature